Herpes simplex virus therapy - Nova BioGenetics
Alternative Names: HSV therapy - Nova BioGeneticsLatest Information Update: 04 Nov 2017
At a glance
- Originator Nova BioGenetics
- Class Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Herpes simplex virus infections
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for phase-I development in Herpes-simplex-virus-infections in USA (Topical)
- 24 Apr 2007 Preclinical development is ongoing
- 23 Jun 2003 Phase-I clinical trials in Herpes simplex virus infections treatment in USA (Topical)